Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Neuropathology. 2011 Jan 27;31(5):503–509. doi: 10.1111/j.1440-1789.2010.01193.x

Figure 1.

Figure 1

Low magnification photomicrographs of 5-HT1A staining immunostaining in the hippocampus of a control case (Braak stage 0; A), an AD case (Braak stage IV; B), and two advanced AD cases (Braak stage VI) with either preserved (C) or diminished (D) 5-HT1A immunoreactivity.